A combination of two drugs could be an effective treatment for lupus, according to preliminary evidence from a UCLH led trial.
Lupus clues from cellular 'power stations'
Researchers at Imperial College London have revealed crucial insights into systemic lupus erythematosus (SLE).
Previous studies from the same Imperial College researchers have suggested that immune cells called CD8 T cells, which normally help to destroy threats to the body such as viruses, appear to malfunction in SLE patients. This may play a role in the immune system spiralling out of control.
Vitamin D deficiency linked to metabolic changes in patients with lupus
RECOVERY Trial (Covid-19)
There is a national trial in progress called RECOVERY which has four treatment arms, one of which is Hydroxychloroquine (HCQ). . St Thomas’ is recruiting patients and the study is being coordinated by infectious disease, respiratory medicine and critical care consultants. The UK chief investigator is based in Oxford.
Ground-breaking discovery finds new link between autoimmune diseases and a gut bacterium
New discovery could improve diagnosis and treatment of lupus in black Africans
Two variants of an autoimmune disease that affects thousands but is hard to diagnose are relatively common among black Africans, research shows.
The findings, relating to systemic lupus erythematosus, or SLE, could improve diagnosis and treatment of the condition.
They could enable better management of the disease in patients of African descent, particularly in southern Africa, where incidence and mortality rates are relatively high.
